Serial Number
85982292
Owner
FRED HUTCHINSON CANCER RESEARCH CENTERAttorney
Tiffany ConnorsFirst Use Date
Apr 8, 2013
Filing Date
Apr 11, 2013
HICOR Trademark
Serial Number: 85982292 • Registration: 4590021
Trademark Classes
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 16 - Paper Goods
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
Tiffany Connors Ballard Spahr LLP
1301 2nd Ave, Suite 2800
Seattle, WA 98101-3808
United States
Trademark Details
Filing Date
April 11, 2013
Registration Date
August 19, 2014
First Use Anywhere
April 8, 2013
First Use in Commerce
April 8, 2013
Published for Opposition
October 22, 2013
Goods & Services
Educational services, namely, providing seminars, workshops and conferences on the subject of cancer research, cancer outcomes research, cost effective cancer prevention, early detection, and treatment and distribution of informational materials therewith
Printed publications, namely, newsletters, pamphlets, and brochures on cancer research, clinical trial design and implementation, cancer outcomes research, cost effective cancer prevention, early detection, and treatment and cures for cancer and related medical and public health problems
Providing medical and scientific research and analysis services in the field of cancer therapy, care, and treatment of cancer patients; conducting research and analysis relating to outcomes research in cancer; research and analysis in the fields of cancer outcomes research, cost effective cancer prevention, early detection and treatment clinical trials for cancer, and health policy concerning cancer and other chronic diseases
Consulting services related to medical cost management, namely, cost-effectiveness of prevention, early detection, and treatment clinical trials for cancer; business consulting and management related to clinical trial design and implementation
